Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
British Journal of Haematology|December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemiaEnrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Blood Advances|March 1, 2021
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemiaAntonio Pierini, Loredana Ruggeri, Alessandra Carotti, et al.
Blood|June 24, 2016
The genetics of nodal marginal zone lymphomaValeria Spina, Hossein Khiabanian, Monica Messina, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid LeukemiaGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Cell|November 5, 2025
Disparate leukemia mutations converge on nuclear phase-separated condensatesGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Oncotarget|February 21, 2019
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Leukemia & Lymphoma|March 28, 2015
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsFabio Forghieri, Ambra Paolini, Monica Morselli, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
British Journal of Haematology|December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemiaEnrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Blood Advances|March 1, 2021
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemiaAntonio Pierini, Loredana Ruggeri, Alessandra Carotti, et al.
Blood|June 24, 2016
The genetics of nodal marginal zone lymphomaValeria Spina, Hossein Khiabanian, Monica Messina, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid LeukemiaGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Cell|November 5, 2025
Disparate leukemia mutations converge on nuclear phase-separated condensatesGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Oncotarget|February 21, 2019
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Leukemia & Lymphoma|March 28, 2015
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsFabio Forghieri, Ambra Paolini, Monica Morselli, et al.
Pageof 25